Back to Journals » Degenerative Neurological and Neuromuscular Disease

Degenerative Neurological and Neuromuscular Disease

ISSN: 1179-9900


Journal Articles:

- 117 records -

Neuroimaging Correlates of Patient-Reported Outcomes in Multiple Sclerosis

Jakimovski D, Wicks TR, Bergsland N, Dwyer MG, Weinstock-Guttman B, Zivadinov R

Degenerative Neurological and Neuromuscular Disease 2023, 13:21-32

Published Date: 1 February 2023

Ultrasound-Guided Percutaneous Neuromodulation in Multiple Sclerosis: A Case Report

Javier-Ormazábal A, Herrero P, González-Platas M

Degenerative Neurological and Neuromuscular Disease 2023, 13:15-20

Published Date: 27 January 2023

Mitochondrial Toxicant-Induced Neuronal Apoptosis in Parkinson’s Disease: What We Know so Far

Sivagurunathan N, Gnanasekaran Priyadharshini, Calivarathan L

Degenerative Neurological and Neuromuscular Disease 2023, 13:1-13

Published Date: 26 January 2023

Forelimb Resistance Exercise Protects Against Neuromuscular Junction Denervation in the SOD1-G93A Rat Model of ALS

Nishimune H, Stanford KG, Chen J, Odum JD, Rorie AD, Rogers RS, Wheatley JL, Geiger PC, Stanford JA

Degenerative Neurological and Neuromuscular Disease 2022, 12:145-155

Published Date: 22 November 2022

No Vitamin D Deficiency in Patients with Parkinson’s Disease

Kuhn W, Karp G, Müller T

Degenerative Neurological and Neuromuscular Disease 2022, 12:127-131

Published Date: 26 September 2022

The Wahls Behavior Change Model for Complex Chronic Diseases: A Clinician’s Guide

Elliott-Wherry AN, Lee JE, Pearlman AM, Wahls TL

Degenerative Neurological and Neuromuscular Disease 2022, 12:111-125

Published Date: 9 September 2022

Invasive Physiotherapy as a Treatment of Spasticity: A Systematic Review

Javier-Ormazábal A, González-Platas M, González-Sierra E, González-Sierra M

Degenerative Neurological and Neuromuscular Disease 2022, 12:23-29

Published Date: 3 March 2022

The Assessment of Major Histocompatibility Complex (MHC) Class-I Expression in Different Neuromuscular Diseases

Kurdi M, Alshareef A, Bamaga AK, Fadel ZT, Alrawaili MS, Hakamy S, Mohamed F, Abuzinadah AR, Addas BM, Butt NS

Degenerative Neurological and Neuromuscular Disease 2021, 11:61-68

Published Date: 30 December 2021

Melatonin Improves Short-Term Spatial Memory in a Mouse Model of Alzheimer’s Disease

Labban S, Alshehri FS, Kurdi M, Alatawi Y, Alghamdi BS

Degenerative Neurological and Neuromuscular Disease 2021, 11:15-27

Published Date: 6 May 2021

Alzheimer’s Disease – Why We Need Early Diagnosis

Rasmussen J, Langerman H

Degenerative Neurological and Neuromuscular Disease 2019, 9:123-130

Published Date: 24 December 2019

Progressive Multifocal Leukoencephalopathy: Current Insights

Kartau M, Sipilä JOT, Auvinen E, Palomäki M, Verkkoniemi-Ahola A

Degenerative Neurological and Neuromuscular Disease 2019, 9:109-121

Published Date: 2 December 2019

Orphan Drugs In Development For The Treatment Of Friedreich’s Ataxia: Focus On Omaveloxolone

Ghanekar SD, Miller WW, Meyer CJ, Fenelon KJ, Lacdao A, Zesiewicz TA

Degenerative Neurological and Neuromuscular Disease 2019, 9:103-107

Published Date: 15 October 2019

Sialorrhea in patients with ALS: current treatment options

Garuti G, Rao F, Ribuffo V, Sansone VA

Degenerative Neurological and Neuromuscular Disease 2019, 9:19-26

Published Date: 20 March 2019

Efficacy of stem cell therapy in ambulatory and nonambulatory children with Duchenne muscular dystrophy – Phase I–II

Dai A, Baspinar O, Yeşilyurt A, Sun E, İnci Aydemir C, Öztel ON, Capkan DU, Pinarli F, Agar A, Karaöz E

Degenerative Neurological and Neuromuscular Disease 2018, 8:63-77

Published Date: 26 October 2018

Biomarkers of Duchenne muscular dystrophy: current findings

Al-Khalili Szigyarto C, Spitali P

Degenerative Neurological and Neuromuscular Disease 2018, 8:1-13

Published Date: 25 January 2018

Erythrocyte membrane in the evaluation of neurodegenerative disorders

Sadanand A, Janardhanan A, Sankaradoss A, Vanisree AJ, Arulnambi T, Bhanu K

Degenerative Neurological and Neuromuscular Disease 2017, 7:127-134

Published Date: 17 October 2017

Current concepts in multiple sclerosis therapy

Sedal L, Winkel A, Laing J, Law LY, McDonald E

Degenerative Neurological and Neuromuscular Disease 2017, 7:109-125

Published Date: 28 September 2017

Effects of a multimodal intervention on gait and balance of subjects with progressive multiple sclerosis: a prospective longitudinal pilot study

Bisht B, Darling WG, White EC, White KA, Shivapour ET, Zimmerman MB, Wahls TL

Degenerative Neurological and Neuromuscular Disease 2017, 7:79-93

Published Date: 26 June 2017

Characteristics of tongue and pharyngeal pressure in patients with neuromuscular diseases

Umemoto G, Furuya H, Tsuboi Y, Fujioka S, Arahata H, Sugahara M, Sakai M

Degenerative Neurological and Neuromuscular Disease 2017, 7:71-78

Published Date: 30 May 2017

Advances in the treatment of relapsing–remitting multiple sclerosis: the role of pegylated interferon β-1a

Furber KL, Van Agten M, Evans C, Haddadi A, Doucette JR, Nazarali AJ

Degenerative Neurological and Neuromuscular Disease 2017, 7:47-60

Published Date: 24 March 2017

More articles